Shuttle Pharma closes $600K convertible note offering; CEO invests $237.5K

Shuttle Pharmaceuticals Holdings, Inc.

Closed $600,000 of an up to $1.3 million senior secured convertible note and warrant offering.
CEO Anatoly Dritschilo invested $237,500 in the offering.
Notes carry 5% OID, 14.5% interest, 1-year term, convertible at 110% premium; prepayable at 107%.
Warrants for 45% of conversion shares, exercisable at 125% of prior day's closing price.

item 1.01 item 3.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-24-041443
form_type: 8-K
ticker: SHPH
cik: 0001757499
company_name: Shuttle Pharmaceuticals Holdings, Inc.
filed_at: 2024-10-17T23:59:59+00:00
discovered_at: 2026-05-14T18:03:09.489067+00:00
generated_at: 2026-05-30T13:24:17.943920+00:00
sec_items: ["1.01", "3.02", "9.01"]
event_type: debt
sentiment: neutral
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-24-041443
json_url: https://secwatch.observer/filing/0001493152-24-041443.json
markdown_url: https://secwatch.observer/filing/0001493152-24-041443.md
text_url: https://secwatch.observer/filing/0001493152-24-041443.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315224041443/0001493152-24-041443-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1757499/000149315224041443/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

LIQT

LiqTech to convert $3M of $6M debt to equity, pay $3M cash in restructuring

LIQTECH INTERNATIONAL INC June 1, 2026, 5:17 PM ET debt Items 1.01, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: debt similar materiality

Filing page SEC filing

WGRX

Wellgistics Health raises $16.9M via convertible notes at 20% OID; majority shareholders lock up shares

Wellgistics Health, Inc. May 29, 2026, 5:30 PM ET debt Items 1.01, 3.02, 7.01, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: debt similar materiality

Filing page SEC filing

CERO

CERo Therapeutics issues $750K convertible note at 10% interest, convertible at $0.05 floor

CERO THERAPEUTICS HOLDINGS, INC. May 29, 2026, 4:05 PM ET debt Items 1.01, 2.03, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: debt similar materiality

Filing page SEC filing

VSTD

Vestand raises $1M via discounted equity and secured loan from Min Gan Zhe

Vestand Inc. May 28, 2026, 5:13 PM ET debt Items 1.01, 2.03, 3.02, 9.01

same SEC item: 1.01, 3.02, 9.01 same event type: debt similar materiality

Filing page SEC filing

TCPC

BlackRock TCP Capital closes $535.8M CLO securitization, repays existing debt facilities

BlackRock TCP Capital Corp. June 1, 2026, 4:50 PM ET debt Items 1.01, 1.02, 2.03, 9.01

same SEC item: 1.01, 9.01 same event type: debt similar materiality

Filing page SEC filing

VLTO

Veralto issues $725M of 4.850% Senior Notes due 2032, net proceeds ~$718.8M

Veralto Corp June 1, 2026, 4:48 PM ET debt Items 1.01, 8.01, 9.01

same SEC item: 1.01, 9.01 same event type: debt similar materiality

Filing page SEC filing

BFAM

Bright Horizons secures $375M term loan, ups revolver to $1B with 2030 maturity

BRIGHT HORIZONS FAMILY SOLUTIONS INC. June 1, 2026, 4:31 PM ET debt Items 1.01, 2.03, 9.01

same SEC item: 1.01, 9.01 same event type: debt similar materiality

Filing page SEC filing

VVX

V2X refinances $868.5M term loans with new tranche maturing 2030; SOFR+2% margin

V2X, Inc. June 1, 2026, 4:10 PM ET debt Items 1.01, 2.03, 9.01

same SEC item: 1.01, 9.01 same event type: debt similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001493152-24-041443

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.